Home Antibody All anti-FGFR2 antibodies
Anti-FGFR2 TRUEMAB Antibody clone 5F7
TrueMAB Antibodies - Made against Authentic Protein Antigens
Also for FGFR2 (NM_000141)
|Full length human recombinant protein of human FGFR2 (NP_000132) produced in HEK293T cell.|
|WB, IF, FC
||WB 1:2000, IF 1:100, FLOW 1:100
|PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.|
|Purified from mouse ascites fluids by affinity chromatography
|Homo sapiens fibroblast growth factor receptor 2 (FGFR2), transcript variant 1|
|BBDS; BEK; BFR-1; CD332; CEK3; CFD1; ECT1; JWS; K-SAM; KGFR; TK14; TK25|
Entrez Gene 2263 Human
|The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq]. |
|Protein KinaseSecreted ProteinTransmembraneDruggable Genome MAPK signaling pathwayEndocytosisRegulation of actin cytoskeletonPathways in cancerProstate cancer|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FGFR2 (RC217098, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FGFR2.
Western blot analysis of extracts (10ug) from 4 different cell lines by using anti-FGFR2 monoclonal antibody at 1:200 dilution.
Cross-Reactivity of anti-FGFR2 (TA502829) with FGFR1 and FGFR3,not with FGFR4.
HEK293T cells were transfected with the DDK(FLAG)-tagged DNAs of FGFR2 (RC217098),FGFR1(RC202080),FGFR3(RC215533),FGFR4(RC204230) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FGFR2(TA502829).(1:500) and anti-DDK (1:2000), respectively.
Anti-FGFR2 mouse monoclonal antibody (TA502829) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY FGFR2(RC217098 ).
Immunofluorescent staining of HeLa cells using anti-FGFR2 mouse monoclonal antibody (TA502829).
Flow cytometric Analysis of Hela cells, using anti-FGFR2 antibody(TA502829),(Red), compared to a nonspecific negative control antibody,(Blue).
Flow cytometric Analysis of Jurkat cells, using anti-FGFR2 antibody(TA502829),(Red), compared to a nonspecific negative control antibody,(Blue).